AG

Aditi Ganesh Mahajan

Active Director Director DIN 09421423
DIN 09421423 First appointment Aug 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Aditi Ganesh Mahajan

Data last updated:

Aditi Ganesh Mahajan is a Director at Dr Nik Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Dr Nik Pharmaceuticals Private Limited reported revenue of ₹1.6 Lakh (FY 2025).

DIN 09421423
Primary Designation Director
Industry Pharma
First Appointment 07 Aug 2023
Oldest Company Age 3 yrs
Largest company Dr Nik Pharmaceuticals Private Limited · ₹1.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Aug 20232023₹1.6 Lakh (FY 2025)Active

Board colleagues of Aditi Ganesh Mahajan

NameDINCompanyDesignation
Nikita Prashant Borkar10320016Dr Nik Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dr Nik Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Aditi Ganesh Mahajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aditi Ganesh Mahajan

Aditi Ganesh Mahajan currently holds 1 directorship: Dr Nik Pharmaceuticals Private Limited (Director, since 07 Aug 2023, revenue ₹1.6 Lakh (FY 2025)).

Aditi Ganesh Mahajan was first appointed on 07 Aug 2023 as Director at Dr Nik Pharmaceuticals Private Limited.

The current boards of Aditi Ganesh Mahajan's companies include Nikita Prashant Borkar (Dr Nik Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available